The pancreas was identified and a silk suture was passed under the duct near the duodenum for stabilization and temporary occlusion. The biliary duct proximal to the junction of the biliary and pancreatic ducts was occluded temporarily with a forceps to prevent the zein solution from entering the liver. The zein solution (0. I m1/100 g of rat) was injected into the distal duct through a 27-gauge needle attached to a syringe. After closing the abdomen, the animals were returned to their individual cages. Water and food were again offered ad libitum. Sham-operated rats served as control animals. The zein solution contained per ml 37 mg zein (Sigma, St. Louis, MO) dissolved in 0.1 ml of 95% ethanol and suspended in 0.9 ml of linoleic and oleic acids (2: 1 v/v) (Sigma).
To confirm pancreatic hypofunction, a NBT-PABA test was performed 1 wk after the injection of the zein solution. The animals were fasted over night and 1 mg/ 100 g rat of Bentiromide (N-benzoyl-L-tyrosyl-paraaminobenzoate) in 2 ml solution was injected in the stomach through a blunt tipped metal cannula passed down the esophagus. Food and water were offered ad libitzlm after gastric injection and urine was collected for 24 h. Urine paraaminobenzoic acid was determined by the BrattonMarshall reaction after acid hydrolysis (7).
Before breath testing, the animals were kept for 3 months in individual cages with free access to a standard pellet diet, to give time for possible intestinal adaptation to pancreatic hypofunction. After this time interval, the cholesteryl-I-14C-octanoate breath test was performed, and pancreatic function was determined by measurement of NBT-PABA excretion and fat absorption. The animals were then sacrificed, and the chymotrypsin and amylase content in total pancreatic homogenate was determined.
Considerable care was taken to develop a method of emulsifying the practically water-insoluble cholesteryl octanoate in such way that the emulsion was stable and the particle size was small. Preliminary experiments indicated that the nature of the emulsion markedly influenced 14C02 output. The optimal result, i.e. the greatest recovery of 1 4 C 0 2 , was obtained by using 1 : 10: 12 (w/w/w) proportions of cholesteryl octanoate, triglyceride, and lecithin. T o prepare the emulsion, 5 mg cholesteryl octanoate, 50 mg triglyceride, and 60 mg lecithin were dissolved in chloroform in a 20-ml glass liquid scintillation vial. The chloroform was evaporated under a N2-stream so that the substrate remained as a thin layer adherent to the bottom of the vial. Two and onehalf ml of NaCl0.9% were added, and the solution was sonicated in a Brownwill Biosonic (Brownwill Scientific, Rochester, NY) for 20 min with an energy output of 200 W in an ice bath under an N2 stream (test meal I). The test meal was freshly prepared for each set of experiments, using this technique. The radioactivity concentration of the emulsion was measured prior to administration of the test meal.
To exclude impaired absorption and/or metabolism of octanoate in zein-injected rats, a test meal containing the products of hydrolysis of cholesteryl octanoate (1.9 pmol cholesterol and 1.9 Fmol 14C-octanoic acid) was administered as a positive control (test meal 11). Preparation of the test meal was identical to the one described above.
Another positive control was performed by feeding zein-injected rats with pancreatic enzymes 5 min prior to administration of test meal I. Pancreatic enzymes consisted of 114 capsule Cotazyme which was equal to 2000 USP units lipase, 7500 USP units protease, and 7500 units amylase. The capsule was suspended in 5 ml of isotonic saline (test meal 111).
Animals were fasted over night prior to each experiment. After administration of 0.5 ml of the test meal, containing 1 mg of cholesteryl octanoate (200,000 dpm) by a n intragastric tube, the animals were immediately placed in the glass cage of the COz trapping train.
Test meal I (cholesteryl-l4C-octanoate), test meal I1 (cholesterol and 14C-octanoic acid), and test meal I11 (cholesteryl-14C-octanoate and pancreatin) were administered to zein-injected rats, whereas control animals received only test meals I and 11.
The COz trapping train consisted of a glass cage for the animal with a volume of 1.8 liter and four gas bubblers connected by tubing to a vacuum line. The trapping solution in the bubbler consisted of 5 ml ethanolamine and methoxyethanol (I: 1 v/v). C 0 2 trapping was highly efficient, leading to a 95% retention of radioactivity in the first bubbler and more than 4% in the second bubbler. Less than 1% of radioactivity was lost. Samples were counted after adding 4 ml of methanol and 10 ml of a Toluenebased scintillation cocktail (Aquasol NEN) to the trapping fluid. Counts were converted to disintegrations per min by external standardization. The results were expressed either as percentage of administered dose per min or as cumulative recovery in percent of administered dose.
For feces collection, animals were housed in individual metabolic cages with free access to water and a standard diet containing 6% fat. After 3 days. feces were collected and food intake was measured for 3 days. The 3-day stool was pooled, freeze dried, and investigated for fecal fat according to Jover and Gordon ( 8 ) .
For in vitm amylase and chymotrypsin measurements the rats were sacrificed using ether and the pancreas was removed. The tissuc was homogcnized in 5 ml isotonic saline at 4" C. Amylase activity was estimated in the total pancreatic homogenate using the starch-iodine procedure (9). and chymotrypsin activity was measured with bentiromide after trypsin activation (10).
Cholesteryl-I-l4C-octanoate was synthesized and supplied by Dr. Herok of Hoechst AG, Frankfurt/Main, West Germany. Radiopurity was checked by TLC, HPLC and G C and was found to be 99%. The specific activity was 22.4 mCi/g.
Nonradioactive cholesteryl octanoate was synthesized by reacting cholesterol with octanyl chloride in water-free pyridine. The product was purified by several recrystallization steps in ethanol and its purity was checked by TLC. Lecithin was prepared from hen's egg yolk according to Singleton ct ul. (1 1). For preparation of the test meal, cholesterol-free vegetable oil was used. Cholesterol A grade was obtained from CalBioChem and 14C-octanoic acid was purchased from NEN. Statistical analysis was conducted using the Wilcoxon rank sum test. Figure 2 shows the 14C02 recovery over a 110-min period expressed as percent of dose administered after feeding I mg of 14C-labeled cholesteryl octanoate (test meal I) to zein-injected rats and control animals. The appearance of 14C02 in the breath of control animals was very rapid, leading to a peak of radioactivity output as soon as 10-20 min after feeding. In contrast to these findings, 14C02 output in zein-injected rats increased slowly after feeding; in most rats peak collections were delayed pancreatic function for several reasons. In the intestinal lumen, cholesterol esters are hydrolyzed by carboxyl ester lipase (cholesterol esterase) to cholesterol and fatty acid (12), which subsequently can be absorbed through the mucosa (13). Enzymatic hydrolysis of dietary fat begins in the stomach, where 10-40% of the total dietary triglyceride may be digested (44). In humans and most mammals, the major gastric lipase is lingual lipase, an enzyme secreted from lingual serous glands (15). In contrast to triglycendes, phospholipids and cholesterol esters are resistant to lingual lipase (16). In addition to being present in pancreatic secretion, carboxyl ester lipase activity is also measurable in the intestinal mucosa. This enzymatic activity is believed to be of pancreatic origin, since rats subjected to external drainage of pancreatic juice shpw an absence of carboxyl ester lipase in the intestine (17). Hence, carboxyl ester lipase is a digestive enzyme secreted mainly, if not exclusively, by the exocrine pancreas. The value of cholesterol esterase as a marker enzyme for exocrine pancreatic insufficiency is supported by the encouraging results with the fluorescein dilaurate test (1 8), which also measures the activity of carboxyl ester lipase (cholesterol esterase) (19).
RESULTS
Peak recovery of 14C02 in breath occurred as early as 20 min after administration of the test meal. The rapid recovery of 14C02 is believed to be due to the unique properties of octanoic acid, namely its rapid, passive absorption (20) and the absence of esterification in the enterocyte, its transport to the liver in portal blood, and its rapid and complete oxidation in the liver or other tissues (2 1). In contrast to long-chain fatty acids, which are transported via the thoracic duct, most short-chain fatty acids, i.e. those with less than 12 carbon atoms, are absorbed directly into the portal venous system (22) and d o not require bile acids for absorption, since they have considerable water solubility (23). However, pancreatic carboxyl ester lipase does require bile salts to be present at micellar concentration for full enzyme activity (1 2).
The functional degree of pancreatic insufficiency was determined by the result of fat absorption and the NBT-PABA test, which was performed 1 wk after and 3 months after the injection of zein. Although the enzyme content in pancreatic homogenate revealed a significant degree of pancreatic insufficiency, fat and PABA excretion appeared to be normal at the time of breath testing. The observed shift in PABA excretion from significantly reduced levels right after the injection of zein to control values 3 months later, could be explained in a number of ways. A regeneration of destroyed pancreatic tissue seems unlikely in this model of pancreatic insufficiency (6). Although the NBT-PABA test has been successfully used to assess pancreatic function in humans (24) and rats (7), certain limitations regarding the tests specificity and sensitivity have been reported. PABA excretion was found after exclusion of pancreatic secretions from the intestine in rats (25) and after total pancreatectomy in humans (1 8). Certain nonpancreatic enzymes of bacterial and mucosal origin were shown to be capable of 25) . It could be speculated that in long-standing pancreatic insufficiency bacterial overgrowth and/or adaptation of mucosal enzymes leads to recovery of NBT-PABA hydrolysis.
In zein-injected rats, the reduction of chymotrypsin activity in the pancreatic homogenate was much less pronounced than the reduction of amylase activity. Similar discordant changes of enzyme content were observed in the duct ligation model of pancreatic insufficiency, where amylase was found t o be decreased by 54%, while trypsin was reduced by only 33% (27) . In accordance to these findings, we reported in a recent study that the relative content of protease in pancreatic homogenate rises with the degree of pancreatic insufficiency (28). This shift in enzyme production seems to be a n adaptive process of the remaining exocrine pancreas to the loss of exocrine tissue. The nonproportional increase of trypsin and chymotrypsin might be another explanation for the insensitivity of the PABA test in this situation.
Zein-injected rats did not show an impairment in fat absorption. Similar observations were made with another model for pancreatic insufficiency. Again, rats with severe pancreatic insufficiency had a normal fat absorption, when fed a standard diet (Mundlos S, Adler G, Hausmann W, unpublished observations) despite a 99% reduction of lipase activity in pancreatic homogenate. This somewhat surprising capacity of fat digestion in severe pancreatic malfunction might be due to adaptive processes leading to significant lipase production from sites other than the pancreas. In the rat, as well as in humans, lingual lipase and gastric lipase are known to play an important role in fat digestion (15). Initial lipolysis in the stomach by lingual and/or gastric lipase becomes a much more important process in conditions of pancreatic insufficiency and may in part compensate the lack of pancreatic digestive capacity (29). It was suggested that preduodenal, i.c. nonpancreatic digestion, contributes to the assimilation of 60-70% of ingested fat in children with cystic fibrosis or congenital lipase deficiency (30). Similar adaptive processes in the rat seem likely.
Since the time course of 14C02 excretion after cholesteryl-14C-octanoate was practically identical to that after cholesterol and 14C-octanoic acid, it seems unlikely that lipolysis was the rate-limiting step in the process involving digestion, absorption, and metabolism of cholesteryl octanoate in control animals. It is assumed that in control animals the metabolism of the octanoic acid to 14CO2, rather than hydrolysis, was the important determinant of 14C02 excretion. However, this was not the case in zein-injected rats, as either feeding of pancreatic enzymes prior to the test meal or administration of hydrolyzed cholesteryl-14C-octanoate fully restored the depressed 14CO2 excretion. Thus, the rate-limiting step was lipolytic digestion, i.e. hydrolysis of the marker molecule, due to the lack of pancreatic enzymes.
Our data suggest that cholesteryl-l4C-octanoate can be used as a noninvasive procedure to assess exocrine pancreatic function in experimental animals. The procedure described herein has been modified and in preliminary studies gives similar results in adults with pancreatic exocrine insufficiency (3 1). In this study,
